Tibet Weixinkang Medicine Co., Ltd.
SSE:603676.SS
11.51 (CNY) • At close June 9, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| 246.169 | 214.017 | 176.959 | 95.911 | 58.425 | 55.678 | 73.436 | 101.587 | 114.915 | 113.027 | 116.201 | 87.743 |
| Afschrijvingen & Amortisatie
| 52.892 | 48.575 | 40.934 | 34.088 | 31.084 | 26.826 | 22.635 | 18.519 | 18.535 | 12.127 | 9.192 | 6.974 |
| Uitgestelde Inkomstenbelasting
| 0 | -23.74 | -17.624 | 2.709 | 2.126 | 1.504 | -1.793 | 2.427 | -1.725 | -5.066 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 22.45 | 20.297 | 0 | 0 | 0 | 0 | 1.602 | 3.246 | 0 | 0 |
| Verandering in Werkkapitaal
| 61.485 | -3.099 | -3.111 | 22.372 | 54.574 | 30.096 | 6.799 | -56.957 | -30.536 | -14.819 | -6.712 | -26.979 |
| Vorderingen
| 13.111 | 34.559 | -25.404 | 24.397 | 61.251 | -33.929 | -180.298 | -139.284 | 36.761 | 35.937 | 135.848 | 0 |
| Voorraden
| -6.316 | -6.499 | -9.165 | -3.299 | -8.638 | -4.407 | 25.754 | 12.388 | -16.981 | -8.193 | -6.788 | -11.827 |
| Crediteuren
| 0 | -7.419 | 49.083 | -1.435 | -0.166 | 66.927 | 163.136 | 67.512 | -48.59 | -37.498 | 0 | 0 |
| Overig Werkkapitaal
| 54.69 | -23.74 | -17.624 | 2.709 | 2.126 | 1.504 | -18.956 | -69.345 | -13.555 | -6.626 | 0.076 | -15.153 |
| Overige Niet-Contante Posten
| 12.235 | 20.919 | 25.638 | -4.688 | -10.385 | -6.259 | -19.702 | 0.151 | 0.873 | 4.134 | -0.209 | 20.851 |
| Kasstroom uit Operationele Activiteiten
| 372.781 | 256.672 | 246.154 | 170.689 | 133.698 | 106.341 | 83.168 | 63.301 | 103.788 | 114.469 | 118.472 | 88.589 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -58.176 | -70.814 | -77.694 | -55.599 | -54.349 | -43.653 | -94.496 | -77.764 | -26.402 | -43.293 | -70.973 | -97.286 |
| Netto Overnames
| 0 | 0 | 0 | 0.324 | 0.035 | 0.04 | 35.065 | 0.003 | 0 | -3 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | -15 | -1,651.423 | -28.5 | -7.5 | -9 | -1,195.16 | -0.023 | -10.783 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 27.163 | 19.871 | 16.912 | 13.165 | 14.09 | 14.344 | 15.176 | 7.08 | 2.651 | 1.642 | 2.439 | 2.109 |
| Overige Investeringsactiviteiten
| -178.943 | -338.269 | 180.995 | 1,540.823 | 13.9 | -40.9 | 56.752 | -307.057 | -70.5 | -43.293 | 0.052 | 0.548 |
| Kasstroom uit Investeringsactiviteiten
| -209.956 | -389.212 | 105.213 | -152.709 | -54.824 | -77.669 | 3.497 | -377.742 | -94.274 | -55.434 | -68.481 | -94.629 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.14 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | -3.171 | -0.716 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -177.848 | -97.839 | -69.626 | -40.185 | -19.035 | -23.265 | -34.364 | -3.452 | -56.552 | 0 | -62.824 | 0 |
| Overige Financieringsactiviteiten
| -39.556 | -4.597 | -7.163 | 46.459 | 0 | 9.99 | 26.605 | 293.999 | 0 | -0.282 | -9.401 | -1.104 |
| Kasstroom uit Financieringsactiviteiten
| -217.404 | -102.436 | -75.819 | 6.274 | -19.035 | -13.275 | -7.759 | 290.546 | -56.552 | -0.282 | -72.225 | -1.104 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.491 | 0.635 | 0 | 0 | -0 | -0 | -0 | 0 | -0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -54.088 | -249.896 | 275.548 | 24.254 | 59.838 | 15.397 | 78.906 | -23.895 | -47.038 | 58.753 | -22.234 | -7.144 |
| Kaspositie aan het Einde van de Periode
| 215.338 | 269.426 | 519.322 | 243.774 | 219.52 | 159.682 | 144.285 | 65.38 | 89.274 | 136.312 | 77.559 | 99.793 |